Pharmafile Logo

Peter Impey

- PMLiVE

Lilly taps Strides Arcolab for cancer generics

Aims to expand its presence in emerging pharmaceutical markets

- PMLiVE

BMS cuts Orencia price to win NICE over

Draft guidance now backs drug for earlier stage of rheumatoid arthritis treatment

- PMLiVE

Pfizer reports strong data with new breast cancer candidate

Phase II results suggest progression-free survival benefits for PD-0332991

- PMLiVE

Novo launches haemophilia tracking app

Will compete with similar apps from Pfizer, Baxter

- PMLiVE

Healthwatch England names Katherine Rake as director

Former advisor to Prime Minister will lead body to give patients in England a say in health policy

UK flag

UK budget 2012: Industry welcomes £600m for science research

Chancellor also makes new cut in corporation tax and plans next steps to support life sciences

- PMLiVE

Cromsource appoints Dr Christian Milla to head-up medical division

He will also serve as the Italian CRO's French country manager

- PMLiVE

One man’s junk: What non-coding DNA means for pharma

ENCODE has identified 400 regions of ‘junk’ or non-coding DNA that may have a bearing on disease states, and the implications for pharma and patients are huge

- PMLiVE

1992 – 2012: The ethics we work within

When commercialisation of the internet began in the 1990s we could never have anticipated how significant a part audience ‘pull’ of information would become. So is it pharma and its...

- PMLiVE

IMI unveils €237m backing for drug development projects

Includes projects involving data sharing, stem-cells and biologic drug delivery

- PMLiVE

Baxter expands kidney disease business with $4bn Gambro deal

Strengthens haemodialysis portfolio with purchase of Swedish medical tech firm

- PMLiVE

MP: Daiichi Sankyo’s expansion is endorsement of UK life sciences

Pharma company enlarges its UK early-stage development base

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links